Data / Drug companies / New World Imports, Inc
New World Imports, Inc: 63 products in the FDA NDC directory, labeler code 51824
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
New World Imports, Inc (labeler code 51824) lists 63 products in the FDA National Drug Code Directory, covering 29 finished drugs by generic name. By type: 63 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 8, 2026.
The request: Watch New World Imports, Inc (FDA labeler code 51824): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51824
- Products in commercial distribution
- 63
- Packages
- 119
- Finished drugs by generic name
- 29
- Prescription products
- 0
- Over the counter products
- 63
- Flagged as original packager
- 56 of 56 products that carry the flag
- Started marketing in the last 12 months
- 9
- Products with a marketing end date set
- 4
- Earliest marketing start
- September 16, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 58 | 92.1% |
| Generic drugs (ANDA) | 5 | 7.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 63 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 7 | 214 |
| Hydrocortisone | 5 | 171 |
| Sodium fluoride | 4 | 124 |
| Petrolatum | 4 | 74 |
| Clotrimazole | 3 | 98 |
| Aluminum chlorohydrate | 3 | 46 |
| Acetaminophen, diphenhydramine hcl | 3 | 42 |
| Diphenhydramine hydrochloride | 2 | 127 |
| Bacitracin zinc | 2 | 39 |
| Menthol | 2 | 263 |
| Bacitracin zinc, neomycin sulfate, polymyxin b sulfate | 2 | 44 |
| Aspirin | 2 | 134 |
| Mineral oil, petrolatum, phenylephrine hcl | 2 | 28 |
| Naproxen sodium | 2 | 100 |
| Menthol, methyl salicylate | 2 | 36 |
| Sodium monofluorophosphate | 2 | 53 |
| Alcohol | 2 | 293 |
| Miconazole nitrate | 1 | 101 |
| Ibuprofen | 1 | 190 |
| Diphenhydramine hydrochloride and zinc acetate cream | 1 | 1 |
| Tolnaftate | 1 | 99 |
| Benzalkonium chloride, lidocaine hcl | 1 | 4 |
| Loratadine | 1 | 125 |
| Cetirizine hcl | 1 | 48 |
| Camphor, menthol, eucalyptus | 1 | 1 |
| Potassium nitrate and sodium fluoride | 1 | 7 |
| Sennosides | 1 | 65 |
| Capsaicin | 1 | 66 |
| Zinc oxide | 1 | 595 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 18 | 28.6% |
| Tablet | 16 | 25.4% |
| Ointment | 10 | 15.9% |
| Paste, dentifrice | 6 | 9.5% |
| Gel | 4 | 6.3% |
| Tablet, coated | 3 | 4.8% |
| Solution | 2 | 3.2% |
| Gel, dentifrice | 1 | 1.6% |
| Spray | 1 | 1.6% |
| Jelly | 1 | 1.6% |
| Tablet, chewable | 1 | 1.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Freshmint Anticavity Fluoride | 51824-123 | Paste, dentifrice | Over the counter monograph drugs | September 8, 2026 |
| CAREALL Clotrimazole | 51824-121 | Cream | Over the counter monograph drugs | August 1, 2026 |
| CAREALL Musle and Joint | 51824-120 | Gel | Over the counter monograph drugs | August 1, 2026 |
| CAREALL Hemorrhoidal | 51824-119 | Ointment | Over the counter monograph drugs | August 1, 2026 |
| CareALL Triple Antibiotic plus Pain Relief | 51824-118 | Ointment | Over the counter monograph drugs | August 1, 2026 |
| CareALL Triple Antibiotic | 51824-117 | Ointment | Over the counter monograph drugs | August 1, 2026 |
| CAREALL Bacitracin | 51824-116 | Ointment | Over the counter monograph drugs | August 1, 2026 |
| CAREALL Hydrocortisone Maximum Strength | 51824-114 | Cream | Over the counter monograph drugs | August 1, 2026 |
| CAREALL Hydrocortisone Maximum Strength | 51824-197 | Cream | Over the counter monograph drugs | June 15, 2026 |
| CAREALL Naproxen Sodium | 51824-109 | Tablet | Generic drugs (ANDA) | August 23, 2024 |
| CAREALL Pain Relief PM Extra Strength | 51824-108 | Tablet | Over the counter monograph drugs | August 23, 2024 |
| CareALL Acetaminophen Extra Strength | 51824-101 | Tablet | Over the counter monograph drugs | August 23, 2024 |
| CareALL Hand Sanitizer | 51824-110 | Gel | Over the counter monograph drugs | June 12, 2024 |
| CAREALL Pain Relief PM Extra Strength | 51824-107 | Tablet | Over the counter monograph drugs | January 10, 2024 |
| CareALL First Aid Burn Cream | 51824-096 | Cream | Over the counter monograph drugs | January 2, 2024 |
| CAREALL Hydrocortisone Maximum Strength | 51824-098 | Cream | Over the counter monograph drugs | January 1, 2024 |
| CAREALL Hydrocortisone Maximum Strength | 51824-097 | Cream | Over the counter monograph drugs | January 1, 2024 |
| CAREALL Muscle Rub Ultra Strength | 51824-105 | Cream | Over the counter monograph drugs | December 12, 2023 |
| CAREALL Allergy Relief | 51824-104 | Tablet | Generic drugs (ANDA) | December 7, 2023 |
| CAREALL Allergy Relief | 51824-103 | Tablet | Generic drugs (ANDA) | December 7, 2023 |
| CAREALL Allergy Relief | 51824-102 | Tablet, coated | Over the counter monograph drugs | December 6, 2023 |
| CareALL Acetaminophen Extra Strength | 51824-099 | Tablet | Over the counter monograph drugs | November 28, 2023 |
| CAREALL Vitamin A and D | 51824-095 | Ointment | Over the counter monograph drugs | May 19, 2023 |
| CAREALL Clotrimazole | 51824-093 | Cream | Over the counter monograph drugs | July 1, 2022 |
| CAREALL Anti-Itch | 51824-088 | Cream | Over the counter monograph drugs | July 1, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.